%20Medical%20Technology.png&w=3840&q=75)
Puliyan (Nanjing) Medical Technology Co., Ltd. is excited to announce a landmark funding achievement of 50,000,000, marking a significant milestone in our journey to redefine medical innovation. Based at Floor 5, Building 07, Life Science Island in Jiangbei New District, Nanjing, and operating a dedicated manufacturing facility at Building 9, Zhongnan Smart Valley Industrial Park, our company stands at the forefront of medical technology advancement. Our state-of-the-art facility spans 5,200㎡ and includes specialized clean production zones—1,000㎡ each for Class 100,000 and Class 10,000 environments—designed to meet the highest standards of production quality and safety.
This funding will play a pivotal role in expanding our capability in engineered manufacturing of PLLA microspheres and micronization of animal-derived acellular matrices, addressing critical bottlenecks that have long constrained advancements in foundational materials and processes for medical devices. By leveraging our deep clinical insight and a comprehensive understanding of the aesthetic needs within the medical industry, we have already pioneered a series of high-value absorbable medical devices. With this new injection of capital, Puliyan (Nanjing) Medical Technology is poised to enhance its R&D initiatives, drive innovation in product development, and expand our comprehensive industrial chain for absorbable medical products.
Our commitment to quality, innovation, and excellence remains unwavering as we continue to transform the landscape of medical device manufacturing. This funding not only empowers us to push the boundaries of medical science but also reinforces our mission to deliver transformative solutions that significantly improve patient outcomes and elevate industry standards. We are thrilled to embark on this next chapter of growth, innovation, and market leadership.
